(Q40382023)

20 September 2017

title

Prostate cancer cell lines lack amplification: overexpression of HER2. (English)

1 reference

20 September 2017

1 reference

Anders Ullén

1

1 reference

20 September 2017

Lena Lennartsson

2

1 reference

20 September 2017

Ulrika Harmenberg

3

1 reference

20 September 2017

Bo Lennernäs

4

1 reference

20 September 2017

Khairul Majumder

5

1 reference

20 September 2017

Anders R Holmberg

6

1 reference

20 September 2017

Sten Nilsson

7

1 reference

20 September 2017

Göran P Elmberger

8

1 reference

20 September 2017

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

44

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

490-495

1 reference

20 September 2017

cites work

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Management of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Antitumor effect of an HER2-specific antibody-toxin fusion protein on human prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860510029888

10.1080/02841860510029888

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference